跳至主要内容
临床试验/IRCT201701089157N5
IRCT201701089157N5已完成3 期

Investigation of the prophylactic effects of lisinopril in comparison to placebo on chronic migraine

Iranian Center of Neurological Research, Tehran University of Medical Sciences,0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Patients will be included in the study due to the following inclusion Criteria:
  • having = 15 headache days per month for at least 3 months,
  • history of migraine for at least 1 year,
  • age 18-45 years,
  • systolic blood pressure between 110-140 mmHg
  • Taking a large amount of abortive drugs.
  • The exclusion criteria were as follows:
  • having psychiatric illness,
  • having major neurological disorders and / or other chronic or systemic diseases,
  • being pregnant or have a planned pregnancy,
  • breastfeeding,
  • taking prophylactic medications in the last 4 weeks,
  • suffering from impaired liver function or kidney disorders,
  • allergies to ACE inhibitors,
  • history of angionearotic edema
  • suffering from secondary headaches.

排除标准

  • 未提供

研究者

发起方
Iranian Center of Neurological Research, Tehran University of Medical Sciences,

相似试验